SCHEMBL17057799

SCHEMBL17057799

CC(C)CN1CCN(c2cnn(-c3ccccc3N)c(=O)c2OC2CCCC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MCHR1 Q99705 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ADRA1A P35348 2/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ SCN9A Q15858 1/20 0.33
▸ SCN10A Q9Y5Y9 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899776 0.86 ADRA2C (0.48) SMN1; SMN2KDM4EMEN1KMT2AUSP2
SCHEMBL17058354 0.86 MCHR1 (0.38) SMN1; SMN2MCHR1MEN1KMT2AADRA1A
SCHEMBL11944442 0.84 CACNB4 (0.38) SMN1; SMN2MCHR1MEN1KMT2AUSP2
SCHEMBL17058087 0.83 MCHR1 (0.34) SMN1; SMN2MCHR1MEN1KMT2AADRA1A
SCHEMBL17058267 0.81 SMN1; SMN2 (0.43) SMN1; SMN2KDM4EMCHR1KMT2AGAA
SCHEMBL11944450 0.79 MAPT (0.42) SMN1; SMN2
SCHEMBL14081346 0.79 NPC1 (0.32) SMN1; SMN2MEN1KMT2AUSP2GAA
SCHEMBL14899736 0.76 NCF1 (0.50) SMN1; SMN2KMT2AHTR1A
SCHEMBL11944591 0.75 MAPT (0.38) MCHR1USP2
SCHEMBL11944557 0.73 GPR6 (0.38) SMN1; SMN2MCHR1MEN1KMT2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback